Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:403709.
doi: 10.1093/ecam/neq056. Epub 2011 Mar 10.

New perspectives on chinese herbal medicine (zhong-yao) research and development

Si-Yuan Pan  1 , Si-Bao Chen, Hong-Guang Dong, Zhi-Ling Yu, Ji-Cui Dong, Zhi-Xian Long, Wang-Fun Fong, Yi-Fan Han, Kam-Ming Ko
Affiliations

New perspectives on chinese herbal medicine (zhong-yao) research and development

Si-Yuan Pan et al. Evid Based Complement Alternat Med. 2011.

Abstract

Synthetic chemical drugs, while being efficacious in the clinical management of many diseases, are often associated with undesirable side effects in patients. It is now clear that the need of therapeutic intervention in many clinical conditions cannot be satisfactorily met by synthetic chemical drugs. Since the research and development of new chemical drugs remain time-consuming, capital-intensive and risky, much effort has been put in the search for alternative routes for drug discovery in China. This narrative review illustrates various approaches to the research and drug discovery in Chinese herbal medicine. Although this article focuses on Chinese traditional drugs, it is also conducive to the development of other traditional remedies and innovative drug discovery.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Approaches in R&D of CHM.
See this image and copyright information in PMC

References

    1. Tobinick EL. The value of drug repositioning in the current pharmaceutical market. Drug News and Perspectives. 2009;22(2):119–125. - PubMed
    1. Schmid EF, Smith DA. Keynote review: is declining innovation in the pharmaceutical industry a myth? Drug Discovery Today. 2005;10(15):1031–1039. - PubMed
    1. Schmid EF, Smith DA. R&D technology investments: misguided and expensive or a better way to discover medicines? Drug Discovery Today. 2006;11(17-18):775–784. - PubMed
    1. Reichert JM, Rochon SL, Zhang BD. Finding value in the U.S. Food and Drug Administration’s Fast Track program. Drug News and Perspectives. 2009;22(1):53–58. - PubMed
    1. Graul AI. Promoting, improving and accelerating the drug development and approval processes. Drug News and Perspectives. 2008;21(1):36–43. - PubMed

LinkOut - more resources